Trophic serves as a strategic partner for all aspects of communications for life science companies. We apply a deep understanding of both the science and business of drug development and the capital needed for success. Based on breadth and depth of experience, Trophic has become the go-to advisory for presenting corporate stories and scientific concepts. Current client portfolio ranges from biotech start-ups, listed biopharmas and small and large pharmaceutical companies.

TROPHIC TWITTER FEED

Follow us on Twitter to stay tuned on biotech news and the inner workings of the Trophic team

Spotted: the Trophic Team out and about toasting to our very own @jacobvinfo for a successful messaging workshop in the beautiful London. Cheers! 🍻

Immunicum was featured in @StockBiotech this past Sunday. See below for links to the full interview which is available both in English and Swedish.

English Version: https://t.co/XRHlzMPhpw
Swedish Version: https://t.co/kG1kkPC5Fr

#BioWinDay2018 is today in Louvain-la-Neuve, Belgium. Our Director Early Development, Kristof Vercruysse is at the conference and ready to answer all questions about Sourcia’s CRO and consulting services.

Load More...